Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancer

International Journal of Gynecological Cancer 2026 Open access

Read full text
Authors: Mostafa F. Eyada, Victoria Michael, Shrina Patel, Jeffrey How, Roni Nitecki Wilke, Amir Anthony Jazaeri, Nicole D. Fleming, Pamela T. Soliman, Anil K. Sood, Shannon Neville Westin, Travis T. Sims
DOI: 10.1016/j.ijgc.2026.104761
Cited by: 0
References: 19

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Reproductive Biology and Fertility

Publication details

Journal / source
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Volume
36
Issue
8
Pages
104761–104761
Publication date
15 May 2026
Language
EN